| WKN: | 881319 |
| ISIN: | NZFAPE0001S2 |
| Land: | Neuseeland |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Gesundheit |
Weshalb die Fisher & Paykel Health-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 09. November 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2019 | 7,61 | 13,34 | 75,30% |
| 2 | 2014 | 2,32 | 4,00 | 72,41% |
| 3 | 2013 | 1,44 | 2,32 | 61,11% |
| 4 | 2024 | 13,40 | 21,20 | 58,21% |
| 5 | 2017 | 5,62 | 8,53 | 51,78% |
| 6 | 2020 | 13,34 | 19,30 | 44,68% |
| 7 | 2015 | 4,00 | 5,52 | 38,00% |
| 8 | 2006 | 1,75 | 2,26 | 29,14% |
| 9 | 2005 | 1,36 | 1,75 | 28,68% |
| 10 | 2009 | 1,33 | 1,59 | 19,55% |
| 11 | 2010 | 1,59 | 1,71 | 7,55% |
| 12 | 2021 | 19,30 | 20,00 | 3,63% |
| 13 | 2016 | 5,52 | 5,62 | 1,81% |
| 14 | 2012 | 1,42 | 1,44 | 1,41% |
| 15 | 2023 | 13,40 | 13,40 | 0,00% |
| 16 | 2018 | 8,53 | 7,61 | -10,79% |
| 17 | 2025 | 21,20 | 18,70 | -11,79% |
| 18 | 2011 | 1,71 | 1,42 | -16,96% |
| 19 | 2007 | 2,26 | 1,84 | -18,58% |
| 20 | 2008 | 1,84 | 1,33 | -27,72% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2022 | 20,00 | 13,40 | -33,00% |
| 2 | 2008 | 1,84 | 1,33 | -27,72% |
| 3 | 2007 | 2,26 | 1,84 | -18,58% |
| 4 | 2011 | 1,71 | 1,42 | -16,96% |
| 5 | 2025 | 21,20 | 18,70 | -11,79% |
| 6 | 2018 | 8,53 | 7,61 | -10,79% |
| 7 | 2023 | 13,40 | 13,40 | 0,00% |
| 8 | 2012 | 1,42 | 1,44 | 1,41% |
| 9 | 2016 | 5,52 | 5,62 | 1,81% |
| 10 | 2021 | 19,30 | 20,00 | 3,63% |
| 11 | 2010 | 1,59 | 1,71 | 7,55% |
| 12 | 2009 | 1,33 | 1,59 | 19,55% |
| 13 | 2005 | 1,36 | 1,75 | 28,68% |
| 14 | 2006 | 1,75 | 2,26 | 29,14% |
| 15 | 2015 | 4,00 | 5,52 | 38,00% |
| 16 | 2020 | 13,34 | 19,30 | 44,68% |
| 17 | 2017 | 5,62 | 8,53 | 51,78% |
| 18 | 2024 | 13,40 | 21,20 | 58,21% |
| 19 | 2013 | 1,44 | 2,32 | 61,11% |
| 20 | 2014 | 2,32 | 4,00 | 72,41% |